+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715602
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Angina Pectoris Drugs Market is experiencing pivotal changes, driven by advances in drug formulation, evolving regulatory pressures, and strategic initiatives across global regions. Senior decision-makers are navigating a rapidly shifting landscape where innovation, access, and operational resilience define success.

Market Snapshot: Angina Pectoris Drugs Market Growth

The Angina Pectoris Drugs Market grew from USD 1.20 billion in 2024 to USD 1.27 billion in 2025 and is projected to expand at a CAGR of 5.46%, reaching USD 1.65 billion by 2030. Market trends reveal growing demand for advanced therapeutics, including novel drug delivery systems and reformulated generics. Heightened attention to patient adherence and regulatory alignment is shaping competitive positioning, while supply chain complexities and international trade dynamics are influencing manufacturer and payer strategies.

Scope & Segmentation

This report delivers a multi-dimensional analysis across drug classes, dosage forms, administration routes, distribution channels, end users, global regions, and corporate developments.

  • Drug Classes: ACE inhibitors (enalapril, lisinopril); antiplatelet agents (aspirin, P2Y12 inhibitors); beta blockers (nonselective, selective); calcium channel blockers (dihydropyridines, nondihydropyridines); nitrates (long acting, short acting).
  • Dosage Forms: Capsule, injection, patch, tablet.
  • Routes of Administration: Injectable (intramuscular, intravenous), oral (controlled release, immediate release), sublingual (spray, tablet), transdermal (reservoir, single layer).
  • Distribution Channels: Hospital pharmacies, retail pharmacies, online pharmacies (business to business, business to consumer).
  • End Users: Clinics (private, public), homecare (caregiver administered, self administered), hospitals (private, public).
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, and others).
  • Companies Covered: Novartis AG, Pfizer Inc., Sanofi S.A., Bayer AG, AstraZeneca PLC, GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc.

Key Takeaways

  • Precision medicine and integrative therapeutic approaches are redefining the standard of care for angina pectoris, improving patient outcomes through tailored regimens and innovative technologies.
  • Market participants are leveraging collaborations and strategic partnerships to accelerate the development and deployment of new formulations and digital health solutions that facilitate improved adherence and monitoring.
  • Segment differentiation—by drug class and delivery mechanism—creates multiple pathways for market entry and expansion, enabling companies to align products with specific patient demographics and clinical settings.
  • Regional nuances, particularly in reimbursement frameworks and regulatory pathways, demand highly localized strategies for product launch and market access across the Americas, EMEA, and Asia-Pacific.
  • Emerging delivery systems, such as transdermal patches and sublingual sprays, are gaining traction as patient-centric alternatives to traditional oral therapies, reflecting a shift in both clinical protocols and consumer preferences.

Tariff Impact on Market Access

Recent tariff changes on pharmaceutical imports in 2025 have introduced new pressures for angina pectoris drug manufacturers, particularly those reliant on global sourcing for active ingredients and excipients. These policy shifts have increased production costs and led to supply chain adjustments, compelling companies to consider alternative sourcing and localized manufacturing. Healthcare payers and providers are responding by augmenting formulary and reimbursement criteria, while manufacturers explore repurposing and combination therapies with domestic materials. Ongoing policy discussions may influence future exemptions, but short-term volatility persists.

Methodology & Data Sources

Research for this report is based on direct interviews with cardiologists, payers, and industry executives, supported by surveys targeting attitudes toward emerging angina treatments. Supplementary data were drawn from regulatory filings, clinical trial registries, patent and trade information, and company financial documents. Data integrity was reinforced through triangulation and validation processes.

Why This Report Matters

  • Enables evidence-backed decisions on investment, product development, and regional expansion by detailing evolving market structures and trends.
  • Equips leaders with actionable insights into operational risks, supply chain management, and regulatory compliance implications specific to the angina pectoris therapeutics sector.
  • Provides a practical segmentation and competitor analysis framework, supporting tailored strategies for market share growth and product differentiation.

Conclusion

This report provides a comprehensive outlook on the evolving angina pectoris drugs market. It supports informed strategy development by clarifying emerging opportunities, operational challenges, and the factors influencing future therapeutic adoption and success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Angina Pectoris Drugs Market, by Drug Class
8.1. Introduction
8.2. Ace Inhibitors
8.2.1. Enalapril
8.2.2. Lisinopril
8.3. Antiplatelet Agents
8.3.1. Aspirin
8.3.2. P2Y12 Inhibitors
8.4. Beta Blockers
8.4.1. Nonselective
8.4.2. Selective
8.5. Calcium Channel Blockers
8.5.1. Dihydropyridines
8.5.2. Nondihydropyridines
8.6. Nitrates
8.6.1. Long Acting
8.6.2. Short Acting
9. Angina Pectoris Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Injection
9.4. Patch
9.5. Tablet
10. Angina Pectoris Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Intramuscular
10.2.2. Intravenous
10.3. Oral
10.3.1. Controlled Release
10.3.2. Immediate Release
10.4. Sublingual
10.4.1. Spray
10.4.2. Tablet
10.5. Transdermal
10.5.1. Reservoir
10.5.2. Single Layer
11. Angina Pectoris Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Business To Business
11.3.2. Business To Consumer
11.4. Retail Pharmacies
12. Angina Pectoris Drugs Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Private Clinics
12.2.2. Public Clinics
12.3. Homecare
12.3.1. Caregiver Administered
12.3.2. Self Administered
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Americas Angina Pectoris Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Angina Pectoris Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Angina Pectoris Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Pfizer Inc.
16.3.3. Sanofi S.A.
16.3.4. Bayer AG
16.3.5. AstraZeneca PLC
16.3.6. GlaxoSmithKline plc
16.3.7. Merck & Co., Inc.
16.3.8. Johnson & Johnson
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANGINA PECTORIS DRUGS MARKET MULTI-CURRENCY
FIGURE 2. ANGINA PECTORIS DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. ANGINA PECTORIS DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANGINA PECTORIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANGINA PECTORIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANGINA PECTORIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ENALAPRIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LISINOPRIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY P2Y12 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONSELECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DIHYDROPYRIDINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONDIHYDROPYRIDINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 108. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 109. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 110. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 111. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 112. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 113. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 114. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 116. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 117. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 118. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 119. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 124. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 135. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 136. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 137. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 218. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 219. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 222. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 223. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 225. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 226. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 227. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 228. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 230. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 232. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 233. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 235. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 236. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 237. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 240. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 241. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 243. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 244. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 245. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 246. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 251. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 271. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 272. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 273. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 274. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 275. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 276. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 277. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 279. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 280. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 281. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 282. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 284. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 286. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 287. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 291. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 294. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 295. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 297. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 298. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 299. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 300. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 305. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Angina Pectoris Drugs market report include:
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.65 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Angina Pectoris Drugs - Global Strategic Business Report - Product Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Angina Pectoris Drugs Market Size, Share & Trends Analysis Report By Type (Stable Angina, Unstable Angina), By Drug Class (Beta Blockers, Anticoagulants), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Angina Pectoris Drugs Market Size, Share & Trends Analysis Report By Type (Stable Angina, Unstable Angina), By Drug Class (Beta Blockers, Anticoagulants), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Angina Pectoris Drugs Market Report 2025 - Product Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report - Product Image

Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Angina Pectoris- Pipeline Insight, 2025 - Product Image

Angina Pectoris- Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Angina Pectoris Treatment Market

The Angina Pectoris Treatment market within the context of Cardiovascular Drugs is a highly competitive market, with a wide range of products available. These products are used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. Treatment options include lifestyle changes, medications, and surgical procedures. Medications used to treat angina pectoris include nitrates, beta-blockers, calcium channel blockers, and antiplatelet agents. These medications are used to reduce the frequency and severity of angina attacks, as well as to reduce the risk of heart attack and stroke. The Angina Pectoris Treatment market is driven by the increasing prevalence of cardiovascular diseases, the growing elderly population, and the increasing awareness of the importance of preventive healthcare. Some of the major companies in the Angina Pectoris Treatment market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.